跳至主要内容
临床试验/IRCT20200513047418N1
IRCT20200513047418N1已完成3 期

Investigate the Effect of Interaperitoneal ketamin plus bupivacaine administration for pain relief laparascopic cholecystectomy and comparison with bupivacaine alon

Yazd University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • elective laparascopic cholecystectomy
  • age 18 -65 year
  • weight 55-100 kg
  • The duration of surgery is less than two hours.
  • No neurovascular disease, coagulation disorders, cardiovascular disease • No history of ketamine and bupivacaine allergy
  • No history of abdominal surgery

排除标准

  • use of alcohol, painkillers and anti-inflammatory and non-steroidal anti-inflammatory drugs
  • Having chronic pain unrelated to gallbladder disease
  • Dissatisfaction of the patient to continue participating in this study
  • he need for laparotomy during laparoscopy
  • having acute cholecystitis
  • People who could not understand VAS.

研究者

发起方
Yazd University of Medical Sciences

相似试验